ANNALS OF NUCLEAR MEDICINE is a prominent academic journal dedicated to the field of nuclear medicine, published by Springer. With a rich publication history dating back to 1987 and continuing through 2024, this journal serves as a vital resource for researchers and practitioners interested in the latest developments in nuclear imaging, radiopharmaceuticals, and therapeutic applications. Ranked in the second quartile (Q2) for both Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging categories in 2023, it maintains a strong position in the academic community, with an impressive Scopus rank of #104 out of 333 in its field, placing it in the 68th percentile. The journal is not open access but offers a range of access options through institutional or individual subscriptions, ensuring that critical research findings reach a wide audience. By fostering high-quality, peer-reviewed articles, ANNALS OF NUCLEAR MEDICINE plays a crucial role in advancing the understanding and practical application of nuclear medicine techniques, making it an essential journal for professionals and students aiming to stay at the forefront of this evolving discipline.

INVESTIGATIVE RADIOLOGY, published by Lippincott Williams & Wilkins, is a premier peer-reviewed journal dedicated to disseminating innovative research in the fields of radiology, nuclear medicine, and imaging. With a notable impact factor underscored by its impressive ranking—10th out of 333 in its category, positioning it within the 97th percentile—this journal serves as a vital resource for researchers, professionals, and students eager to stay at the forefront of advancements from 1966 to 2024. Although it does not offer open access, the high-quality studies and reviews found within its pages contribute significantly to the understanding and application of modern imaging techniques. Recognized for its Q1 status in both miscellaneous medicine and radiology specializations, INVESTIGATIVE RADIOLOGY continues to play an essential role in shaping the future of diagnostic and therapeutic imaging.

Ultrasound Quarterly is a leading journal published by Lippincott Williams & Wilkins, dedicated to advancing knowledge and practice in the fields of radiology, nuclear medicine, and imaging. Established in 1988, the journal has served as a vital platform for researchers, clinicians, and students seeking to stay abreast of the latest advancements and techniques in ultrasound technology. With an impact factor that reflects its significance in the field—ranking in the Q3 category within its specialty based on the 2023 metrics—this journal reaches a global audience, facilitating knowledge dissemination and fostering innovation. Ultrasound Quarterly publishes original research, reviews, and clinical studies, making it an essential resource for professionals committed to enhancing patient care through effective imaging practices. To explore its comprehensive articles, visit the journal's website for easy access to the latest research findings.

The European Journal of Nuclear Medicine and Molecular Imaging is a prestigious, peer-reviewed journal published by Springer, dedicated to advancing the field of nuclear medicine and molecular imaging. With an impressive impact factor and ranked in the Q1 category for both Medicine and Radiology, Nuclear Medicine and Imaging, this journal is a pivotal platform for researchers and practitioners to disseminate significant findings from 1996 to the present, reflecting the evolution of the field. The journal boasts a notable Scopus rank, standing at #8 out of 333 in its category, placing it in the top 3% of published works, which highlights its critical importance in shaping contemporary practices and research innovations. Although it does not offer an open-access model, the journal provides various access options to ensure that important research is accessible to professionals, students, and academics alike. Through rigorous peer review and a commitment to high-quality publication, the European Journal of Nuclear Medicine and Molecular Imaging plays an essential role in the advancement of nuclear medicine, contributing to better diagnostic and therapeutic outcomes globally.

ACTA RADIOLOGICA, published by SAGE Publications Ltd, is a premier journal dedicated to the evolving field of radiology, bridging the gap between clinical practice and research from its inception in 1921 to its anticipated continuation until 2024. With an ISSN of 0284-1851 and an E-ISSN of 1600-0455, this esteemed journal holds a significant position in the academic landscape, reflected in its 2023 rankings as Q3 in several categories, including Medicine (miscellaneous), Radiological and Ultrasound Technology, and Radiology, Nuclear Medicine and Imaging. Although currently not an open-access journal, ACTA RADIOLOGICA offers robust subscription options allowing a wide readership among researchers, healthcare professionals, and students striving to stay at the forefront of radiological advancements. The journal publishes original research, reviews, and clinical studies that contribute to the understanding and application of imaging technologies, underscoring its vital role in shaping modern medical practices.

Tomography is an esteemed peer-reviewed journal published by MDPI, focusing on a broad spectrum of topics related to medical imaging and diagnostics. Launched in 2015, this Open Access journal serves as a vital platform for researchers, professionals, and students in the fields of medicine, radiology, nuclear medicine, and imaging. With an impressive impact factor reflecting its relevance, the journal has achieved a quartile ranking of Q2 in both Medicine (Miscellaneous) and Radiology, Nuclear Medicine, and Imaging as of 2023. Renowned for disseminating high-quality research, Tomography welcomes original research articles, reviews, and technical notes, fostering innovation and collaboration within the scientific community. Housed in Basel, Switzerland, the journal aims to bridge the gap between fundamental research and clinical application, appealing to a diverse readership eager to advance the field of medical imaging.

The Hellenic Journal of Nuclear Medicine, published by the Hellenic Society of Nuclear Medicine, serves as a pivotal platform for researchers, professionals, and students in the fields of nuclear medicine, radiology, and imaging. Based in Greece and established as a prominent forum since 2004, this journal is dedicated to advancing the understanding and application of nuclear medicine through high-quality original research, reviews, and clinical studies. With an ISSN of 1108-1430 and an E-ISSN of 1790-5427, it has garnered attention within its community, holding a Q3 ranking in the 2023 category of Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging. Despite its current Scopus ranking of #235/333 in the respective fields, the journal is increasingly recognized for its potential to contribute impactful knowledge and innovations. Researchers are encouraged to utilize its resources to enhance their work and contribute to the growing body of knowledge in nuclear medicine. Notably, the journal maintains a commitment to accessible scholarly communication, fostering collaboration among experts across the globe.

The Egyptian Journal of Radiology and Nuclear Medicine, published by Springer, is a premier open access journal that has provided valuable insights and advancements in the fields of radiology and nuclear medicine since its initiation in 2010. With an E-ISSN of 2090-4762, this journal is dedicated to bridging the gap between research and clinical practice, allowing for the dissemination of high-quality research to a global audience. Situated in Germany, it enjoys a robust reputation in the academic community, evidenced by its categorization in the Q3 quartile for 2023, as well as its Scopus ranking, where it holds a position of #225 out of 333 in the domain of Radiology, Nuclear Medicine and Imaging, placing it in the 32nd percentile. The journal's open access model ensures that researchers, professionals, and students can freely access innovative studies, reviews, and case reports that discuss the latest methodologies, technological advancements, and clinical outcomes in radiology and nuclear medicine. As it looks toward its converged years spanning from 2010 to 2024, the Egyptian Journal of Radiology and Nuclear Medicine continues to be an essential resource for advancing knowledge and fostering ongoing collaboration in these critical fields.

Revista Española de Medicina Nuclear e Imagen Molecular, published by Elsevier España SLU, stands as a vital resource in the field of Radiology, Nuclear Medicine, and Molecular Imaging. With an ISSN of 2253-654X, this journal is committed to disseminating high-quality research and advancements in clinical practices, aiming to bridge the gap between theoretical research and application in healthcare. Operating since 2012, it features a robust archive of peer-reviewed articles and case studies, although it currently holds a Q4 ranking in the Scopus category, indicating significant potential for growth and influence within the academic community. The journal is indexed in Scopus, with a rank of 255 out of 333, placing it in the 23rd percentile, which underlines the need for increased contributions from researchers eager to enhance its standing. While it is not an open-access journal, its availability through libraries and institutions ensures that a wide audience can access critical findings and innovations in the rapidly evolving field of nuclear medicine. As we look towards the convergence period from 2012 to 2024, Revista Española de Medicina Nuclear e Imagen Molecular aspires to fortify its role as a cornerstone for collaboration and advancement in nuclear imaging and radiology.

NUKLEARMEDIZIN-NUCLEAR MEDICINE is a prestigious journal published by Georg Thieme Verlag KG, focusing on pivotal advancements in the fields of Nuclear Medicine, Radiology, and Imaging. Established in 1959, this journal has served as a critical platform for disseminating innovative research, reviews, and clinical guidelines until its anticipated convergence in 2024. With an ISSN of 0029-5566 and an E-ISSN of 2567-6407, NUKLEARMEDIZIN is acknowledged in the academic community as a Q3 category journal within Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging as of 2023, highlighting its ongoing contribution to the interdisciplinary dialogue in healthcare. Although the journal does not currently offer open access, it remains accessible to professionals and students through various academic databases, ensuring that cutting-edge knowledge in this growing field is shared widely. Researchers interested in the latest methods and technologies in Nuclear Medicine will find NUKLEARMEDIZIN a valuable resource for enhancing their work and understanding the complexities of modern imaging modalities.